Search Count: 51
 |
Hdac2 In Complex With An Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, KIZ, PG4, PEG, KZF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, KIZ, PG4, PEG, KZF
 |
Structure Of Hdac2 Complexed With An Inhibitory Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PGE, EDO, KJ6, 2OP, PG4, PEG, NHE, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, PGE, EDO, KJ6, 2OP, PG4, PEG, NHE, DMS
 |
Hdac2 In Complex With Inhibitory Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, EDO, KJN, NHE, PG4, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, EDO, KJN, NHE, PG4, PEG
 |
Hdac2 Complexed With An Inhibitory Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, EDO, SHH, KK0, KZF, PG4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, PEG, EDO, SHH, KK0, KZF, PG4
 |
Ligand Binding To Hdac2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, PGE, KJF, NHE, PG4, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, PEG, PGE, KJF, NHE, PG4, EDO
 |
Inhibitory Ligand Binding To Hdac2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: EDO, PG4, PEG, ZN, CA, NA, KKI, NHE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: EDO, PG4, PEG, ZN, CA, NA, KKI, NHE
 |
Ligand Binding To Hdac2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: PEG, PG4, EDO, ZN, CA, NA, KKW, KZF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: PEG, PG4, EDO, ZN, CA, NA, KKW, KZF
 |
Inhibitor Binding To Hdac2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, KRU, NHE, PG4, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-09-21
Ligands: ZN, CA, NA, PEG, KRU, NHE, PG4, EDO
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UMN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UMN
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UNW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UNW
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UO5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UO5
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOH
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EDO, UOE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, EDO, UOE
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOW
 |
Fragment Derived Xiap Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, FUK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-08-22
Ligands: ZN, FUK
 |
Fragment Derived Xiap Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, NA, FUE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-08-22
Ligands: ZN, NA, FUE
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQT
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERZ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EU2